Lung Function Variability in Alpha-1 Antitrypsin Deficiency: Implications for Clinical Trials
Charlie Strange, MD
1,2 Kristen E. Holm, PhD, MPH
2,3 Robert A. Sandhaus, MD, PhD
2,3 David M. Mannino, MD
4 Radmila Choate, PhD, MPH
2,5
Citation: Strange C, Holm KE, Sandhaus RA, Mannino DM, Choate R. Lung function variability in alpha-1 antitrypsin deficiency: implications for clinical trials. Chronic Obstr Pulm Dis. 2026; Published online August 10, 2026. doi: https://doi.org/10.15326/jcopdf.2026.0790
Accuracy, Usefulness, and Impact Variability of ChatGPT-4 for COPD Medication Management: A Modified Delphi Study
Paul M. Boylan, PharmD, BCPS1 Devin L. Lavender, PharmD, BCACP2 Rebecca H. Stone, PharmD, FCCP, BCPS, BCACP2 Russ Palmer, PhD2 Richard L. Lamb, PhD2,3 Kiley Merritt2 Joshua Caballero, PharmD, FCCP, BCPP2
Citation: Boylan PM, Lavender DL, Stone RH, et al. Accuracy, usefulness, and impact variability of ChatGPT-4 for COPD medication management: a modified Delphi study. Chronic Obstr Pulm Dis. 2026; Published online August 4, 2026. doi: https://doi.org/10.15326/jcopdf.2026.0794
Erratum
Jerry A. Krishnan, MD, PhD1 Janet T. Holbrook, PhD2 Elizabeth A. Sugar, PhD2 Richard Albert, MD3 Steve Rennard, MD4 Nina Bracken, APRN1 Jiaxian He, MS2 Marie Bradley, PhD, MSc PH, MPharm5 Kevin Coughlin, MA6 Candace C. Fuller, PhD, MPH6 Bradley Hammill, DrPH, MA7 Elisha Malanga, BS8 Vincent M. Malanga, BS8 David Mannino, MD, MPH8 Richard A. Mularski, MD, MCR, MSHS9 Hugh Musick, MBA1 Jean Rommes, PhD8† Julie DeLisa, MA1 Sengwee Toh, ScD6 Robert A. Wise, MD2
Dynamic Changes in Airway Microbiota and Immune Homeostasis in Patients With COPD and the Implications for Nursing Management
Yao Zhong, Meihua Wang, Qunqun Zhu
Citation: Zhong Y, Wang M, Zhu Q. Dynamic changes in airway microbiota and immune homeostasis in patients with COPD and implications for nursing management. Chronic Obstr Pulm Dis. 2026; Published online July 28, 2026. doi: https://doi.org/10.15326/jcopdf.2026.0799
Trends in the Use of Triple Therapy in Patients With COPD in the United States, 2019 to 2022
Surya P. Bhatt, MD, MSPH1 Brendan Clark, MS, PharmD2 Mary DuCharme, MLIS3 Phani Veeranki, MD, DrPH3 Timothy L. Barnes, PhD, MPH, MHI, MBA3
Citation: Bhatt SP, Clark B, DuCharme M, Veeranki P, Barnes TL. Trends in the use of triple therapy in patients with COPD in the United States, 2019 to 2022. Chronic Obstr Pulm Dis. 2026; Published online July 22, 2026. doi: https://doi.org/10.15326/jcopdf.2026.0781
Protective Effects of Serum Carotenoid Status on Respiratory Health Among Low-Income Individuals With COPD
Mariah K. Jackson, PhD, RDN1 Han Woo, PhD2 Nirupama Putcha, MD, MHS2 Daniel Belz, MD, MPH2 Molly Lauver, BS2 Wendy Lorizio, MD, MPH2 Kirsten Koehler, PhD3 Ashraf Fawzy, MD, MPH2 Corri K. Hanson, PhD, RD1* Nadia N. Hansel, MD, MPH2*
Citation: Jackson MK, Woo H, Putcha N, et al. Protective effects of serum carotenoid status on respiratory health among low-income individuals with COPD. Chronic Obstr Pulm Dis. 2026; Published online July 15, 2026. doi: https://doi.org/10.15326/jcopdf.2025.0710
Low Incidence of High Frequency Chest Wall Oscillation in Bronchiectasis Registry Data Despite Indications and Reimbursement
Amanda E. Brunton1 Radmila Choate2 Christopher J. Richards3 George M. Solomon4
Citation: Brunton AE, Choate R, Richards CJ, Solomon GM. Low incidence of high frequency chest wall oscillation in bronchiectasis registry data despite indications and reimbursement. Chronic Obstr Pulm Dis. 2026; Published online July 15, 2026. doi: https://doi.org/10.15326/jcopdf.2026.0806